Singapore markets closed
Straits Times Index
3,145.81 -5.75 (-0.18%) Nikkei
27,116.11 -195.19 (-0.71%) Hang Seng
17,740.05 -272.10 (-1.51%) FTSE 100
6,991.09 -6.18 (-0.09%) BTC-USD
19,482.01 -583.40 (-2.91%) CMC Crypto 200
444.80 -10.23 (-2.25%)
Takeda Pharmaceutical Company Limited (TAK)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 12:28PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 41.35B |
| Enterprise value | 68.73B |
| Trailing P/E | 30.86 |
| Forward P/E | 10.53 |
| PEG Ratio (5 yr expected) | 0.58 |
| Price/sales (ttm) | 1.71 |
| Price/book (mrq) | 0.95 |
| Enterprise value/revenue | 0.02 |
| Enterprise value/EBITDA | 0.07 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.75 |
| 52-week change 3 | -7.93% |
| S&P500 52-week change 3 | -14.73% |
| 52-week high 3 | 15.36 |
| 52-week low 3 | 12.75 |
| 50-day moving average 3 | 13.67 |
| 200-day moving average 3 | 14.24 |
Share statistics
| Avg vol (3-month) 3 | 2.58M |
| Avg vol (10-day) 3 | 3.34M |
| Shares outstanding 5 | 3.09B |
| Implied shares outstanding 6 | N/A |
| Float 8 | 2.99B |
| % held by insiders 1 | 0.01% |
| % held by institutions 1 | 1.88% |
| Shares short (14 Sept 2022) 4 | 3.44M |
| Short ratio (14 Sept 2022) 4 | 1.6 |
| Short % of float (14 Sept 2022) 4 | N/A |
| Short % of shares outstanding (14 Sept 2022) 4 | 0.11% |
| Shares short (prior month 14 Aug 2022) 4 | 3.2M |
Dividends & splits
| Forward annual dividend rate 4 | 0.73 |
| Forward annual dividend yield 4 | 5.40% |
| Trailing annual dividend rate 3 | 180.00 |
| Trailing annual dividend yield 3 | 1,371.95% |
| 5-year average dividend yield 4 | 4.54 |
| Payout ratio 4 | 134.49% |
| Dividend date 3 | 14 Dec 2009 |
| Ex-dividend date 4 | 29 Mar 2022 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in JPY.Fiscal year
| Fiscal year ends | 30 Mar 2022 |
| Most-recent quarter (mrq) | 29 Jun 2022 |
Profitability
| Profit margin | 5.49% |
| Operating margin (ttm) | 13.96% |
Management effectiveness
| Return on assets (ttm) | 2.35% |
| Return on equity (ttm) | 3.42% |
Income statement
| Revenue (ttm) | 3.59T |
| Revenue per share (ttm) | 1,152.26 |
| Quarterly revenue growth (yoy) | 2.40% |
| Gross profit (ttm) | 2.44T |
| EBITDA | 1.03T |
| Net income avi to common (ttm) | 197.39B |
| Diluted EPS (ttm) | 0.44 |
| Quarterly earnings growth (yoy) | -23.70% |
Balance sheet
| Total cash (mrq) | 645.99B |
| Total cash per share (mrq) | 208.91 |
| Total debt (mrq) | 5.11T |
| Total debt/equity (mrq) | 80.91 |
| Current ratio (mrq) | 1.18 |
| Book value per share (mrq) | 2,042.83 |
Cash flow statement
| Operating cash flow (ttm) | 1.04T |
| Levered free cash flow (ttm) | 771.04B |
© 2022 Yahoo. All rights reserved.
